Assembly Biosciences Inc. (ASMB)
NASDAQ · Healthcare
Assembly Biosciences Inc. EBITDA 2016–2025
Assembly Biosciences Inc. annual/quarterly ebitda history and growth rate from 2017 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Assembly Biosciences Inc. ebitda for the quarter ending March 31, 2026 was -11.3 M, a 14.49% increase year-over-year.
- Assembly Biosciences Inc. ebitda for the twelve months ending March 31, 2026 was -51.4 M.
- Assembly Biosciences Inc. annual ebitda for 2025 was -12.0 M, a 73.53% decrease from 2024.
- Assembly Biosciences Inc. annual ebitda for 2024 was -45.3 M, a 29.45% decrease from 2023.
- Assembly Biosciences Inc. annual ebitda for 2023 was -64.2 M, a 31.43% decrease from 2022.
- Assembly Biosciences Inc. annual ebitda for 2022 was -93.6 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Assembly Biosciences Inc. EBITDA — FAQ
Assembly Biosciences Inc. (ASMB) ebitda over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ASMB's ebitda history?
The chart and table above show Assembly Biosciences Inc.'s ebitda by year and by quarter, including the growth rate.